Yüklüyor......
A Novel Candidate MS2 Phage VLP Vaccine Displaying a tandem HPV L2 Peptide offers Similar Protection in Mice to Gardasil-9
Human papillomaviruses (HPVs) cause approximately 5% of cancer cases worldwide. Fortunately, three prophylactic vaccines have been approved to protect against HPV infections. Gardasil-9, the most recent HPV vaccine, is predicted to offer protection against the HPV types that cause ~90% of cervical c...
Kaydedildi:
| Yayımlandı: | Antiviral Res |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5675787/ https://ncbi.nlm.nih.gov/pubmed/28939477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2017.09.012 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|